Skip to contentSkip to filters

We use cookies for analytics.

Crossing the Goal Line; Bringing Ketamine Treatments to the Clinic

Gerard Sanacora, M.D., Ph.D.

Yale School of Medicine

Recording

1 h 7 min

Abstract

The clinical development of ketamine and esketamine raised new questions about treatment-resistant depression. The speaker traces the discovery of rapid antidepressant effects and examines practical clinical questions about where the evidence supports their use.

Topics